Liver transplant, toxoplasmosis and kidney stones: connecting the dots

BMJ Case Rep. 2019 Feb 15;12(2):e229197. doi: 10.1136/bcr-2019-229197.

Authors

Harini Bejjanki¹, Olanrewaju A Olaoye², Alfonso H Santos², Abhilash Koratala²

Affiliations

¹ Department of Medicine, University of Florida, Gainesville, Florida, USA.
² Department of Nephrology, University of Florida College of Medicine, Gainesville, Florida, USA.

No abstract available

Keywords: infectious diseases; medical management; radiology.

Publication types

Case Reports

MeSH terms

Aftercare
Antimalarials / therapeutic use
Antiprotozoal Agents / adverse effects
Antiprotozoal Agents / therapeutic use
Atovaquone / administration & dosage
Atovaquone / therapeutic use
Brain / diagnostic imaging*
Brain / parasitology
Brain Edema / diagnostic imaging
Female
Humans
Kidney Calculi / chemically induced*
Kidney Calculi / diagnostic imaging
Liver Transplantation / adverse effects*
Magnetic Resonance Imaging / methods
Middle Aged
Pentamidine / adverse effects
Pentamidine / therapeutic use
Pneumonia, Pneumocystis / prevention & control
Sulfadiazine / adverse effects*
Sulfadiazine / therapeutic use
Toxoplasmosis, Cerebral / blood*
Toxoplasmosis, Cerebral / cerebrospinal fluid
Toxoplasmosis, Cerebral / drug therapy
Toxoplasmosis, Cerebral / parasitology
Treatment Outcome
Trimethoprim, Sulfamethoxazole Drug Combination / administration & dosage
Trimethoprim, Sulfamethoxazole Drug Combination / therapeutic use
Ultrasonography / methods

Substances

Antimalarials
Antiprotozoal Agents
Sulfadiazine
Pentamidine
Trimethoprim, Sulfamethoxazole Drug Combination
Atovaquone